09/17/2024 3:32 PM | Collegium Pharmaceutical (Issuer) Smith Thomas B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 9:39 AM | Collegium Pharmaceutical (Subject) Smith Thomas B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024 9:06 AM | Collegium Pharmaceutical (Subject) Smith Thomas B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024 4:52 PM | Collegium Pharmaceutical (Issuer) Kuhlmann Shirley R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2024 10:53 AM | Collegium Pharmaceutical (Subject) Kuhlmann Shirley R. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024 3:47 PM | Collegium Pharmaceutical (Subject) Kuhlmann Shirley R. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024 7:03 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
08/12/2024 1:41 PM | Collegium Pharmaceutical (Subject) McFarlane Neil F. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024 3:34 PM | Collegium Pharmaceutical (Subject) McFarlane Neil F. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024 5:02 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2024 7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2024 3:50 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024 3:36 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 4:22 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 12:59 PM | Collegium Pharmaceutical (Subject) Kuhlmann Shirley R. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024 12:11 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 10:19 AM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144/A | |
05/29/2024 9:05 AM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 3:22 PM | Collegium Pharmaceutical (Issuer) Dreyer Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 11:12 AM | Collegium Pharmaceutical (Subject) Tupper Colleen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 9:05 AM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 3:05 PM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2024 12:01 PM | Collegium Pharmaceutical (Subject) Dreyer Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 6:20 PM | BOHLIN GAREN G (Reporting) Collegium Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 6:21 PM | Collegium Pharmaceutical (Issuer) Heffernan Michael Thomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 6:22 PM | Balice-Gordon Rita J. (Reporting) Collegium Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 6:22 PM | Collegium Pharmaceutical (Issuer) Fallon John A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 6:22 PM | Collegium Pharmaceutical (Issuer) Freund John Gordon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 6:23 PM | Collegium Pharmaceutical (Issuer) McFarlane Neil F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 6:23 PM | Collegium Pharmaceutical (Issuer) Melincoff Gwen A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 6:23 PM | Collegium Pharmaceutical (Issuer) SANTINI GINO (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 2:12 PM | BOHLIN GAREN G (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024 7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2024 7:02 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2024 7:03 AM | Collegium Pharmaceutical (Filer)
| Form DEFA14A | |
05/09/2024 3:07 PM | Collegium Pharmaceutical (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 7:00 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 3:26 PM | Collegium Pharmaceutical (Issuer) Smith Thomas B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:24 PM | Collegium Pharmaceutical (Subject) Smith Thomas B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 3:14 PM | Collegium Pharmaceutical (Issuer) Dreyer Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
War on Elon Escalates… (Ad) Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades.
By doing so he has put himself in the crosshairs of an ideological war with the global elites.
And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. Click here to learn how you can benefit from its widespread distribution. |
02/26/2024 3:39 PM | Collegium Pharmaceutical (Subject) Dreyer Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 11:04 AM | Collegium Pharmaceutical (Subject) EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024 5:06 AM | Collegium Pharmaceutical (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
01/19/2024 1:40 PM | BlackRock Inc. (Filed by) Collegium Pharmaceutical (Subject)
| Form SC 13G/A | |
01/18/2024 3:19 PM | Collegium Pharmaceutical (Issuer) Dreyer Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 7:03 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/22/2023 3:36 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 4:51 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:28 PM | Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 3:32 PM | Collegium Pharmaceutical (Issuer) Kuhlmann Shirley R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 4:00 PM | Collegium Pharmaceutical (Subject) Kuhlmann Shirley R. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023 7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |